Paul Pavli trained in Gastroenterology at Concord and Royal North Shore Hospitals in Sydney and has had an ongoing interest in the basic science and clinical aspects of the inflammatory bowel diseases (IBD) since he finished his specialist training. He completed a PhD in gastrointestinal immunology at the Australian National University (ANU) and has pursued an active research program studying the causes of IBD. Working with researchers from the ANU, he helped establish the Australian Familial IBD Register in the early 1990s, and more recently, has been studying the role of bacteria in triggering IBD.
In parallel he has helped develop a clinical service in IBD at Canberra Hospital where patients have access to all facets of treatment including clinical trials of novel therapies and nursing, surgical, nutritional and psychological support for patients and their families.
Paul has maintained an active role as a teacher and mentor for undergraduate medical students, hospital resident staff and advanced trainees in Gastroenterology who wish to specialise in the management of IBD.
Paul has also served on a number of Federal and Territory government bodies and professional organizations including the Australian Drug Evaluation Committee (ADEC), now the Advisory Committee on Pharmaceutical Medicines (ACPM), the National Health and Medical Research Council (NHMRC), the Royal Australasian College of Physicians, the Gastroenterological Society of Australia and Therapeutic Guidelines.